171 related articles for article (PubMed ID: 24874284)
1. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
[TBL] [Abstract][Full Text] [Related]
2. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of micrometastases and isolated tumor cells in the sentinel node at early stage breast cancer].
Cordero García JM; Palomar Muñoz A; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón A
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):78-82. PubMed ID: 21658817
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I; Guller U; Worni M; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Viehl C; Bronz L; Schnarwyler B; Wight E; Infanger E; Burger D; Koechli OR; Zuber M;
Ann Surg Oncol; 2014 Feb; 21(2):401-7. PubMed ID: 24145993
[TBL] [Abstract][Full Text] [Related]
6. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
[TBL] [Abstract][Full Text] [Related]
7. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
[TBL] [Abstract][Full Text] [Related]
8. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
[TBL] [Abstract][Full Text] [Related]
12. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
13. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
[TBL] [Abstract][Full Text] [Related]
14. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
Calhoun KE; Hansen NM; Turner RR; Giuliano AE
Am J Surg; 2005 Oct; 190(4):588-91. PubMed ID: 16164927
[TBL] [Abstract][Full Text] [Related]
15. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
[TBL] [Abstract][Full Text] [Related]
16. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
17. Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.
Meattini I; Desideri I; Saieva C; Francolini G; Scotti V; Bonomo P; Greto D; Mangoni M; Nori J; Orzalesi L; Fambrini M; Bianchi S; Livi L
Eur J Surg Oncol; 2014 Oct; 40(10):1195-202. PubMed ID: 25179162
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
19. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
[TBL] [Abstract][Full Text] [Related]
20. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
